Picture of Cosmos Pharmaceutical logo

3349 Cosmos Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Table: Cosmos Pharmaceutical -2022/23 parent results

Jul 10 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              May 31, 2023    May 31, 2022   May 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          827.70          755.41                                
               (+9.6 pct)                                              
  Operating       30.10           29.77                                
               (+1.1 pct)                                              
  Recurring       33.07           32.84                                
               (+0.7 pct)                                              
  Net             23.79           23.14                                
               (+2.8 pct)                                              
  EPS          600.71 yen      584.40 yen                              
  Ann Div      100.00 yen       80.00 yen     120.00 yen               
  -Q2 Div       42.50 yen       40.00 yen      60.00 yen               
  -Q4 Div       57.50 yen       40.00 yen      60.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T

Recent news on Cosmos Pharmaceutical

See all news